EyePoint Pharmaceuticals Competitors and Similar CompaniesClear all
EyePoint Pharmaceuticals's competitors and similar companies include Sol-Gel Technologies.
 EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. | |
Founding Date | Founding Date 1987 | Founding Date 1997 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Watertown, US HQ | Locations Ness Ziona, IL HQ |
Employees | Employees 8453% increase | Employees 34 |
Valuation ($) | Valuation ($) 617.6 m | Valuation ($) 18 m |
Financial | ||
Revenue (est.) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) |
Net income | Net income ($232m) (FY, 2025) | Net income ($6.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View company